M&A / Deals Blackstone closes $6.3B fund for life sciences investing BioPharma DiveIt's the biggest life sciences private fund ever raised, coming in nearly 40% larger than its Blackstone predecessor vehicle.M&A / DealsRead full story pharminent March 30, 2026 (Last updated: March 31, 2026) BioPharma Dive It’s the biggest life sciences private fund ever raised, coming in nearly 40% larger than its Blackstone predecessor vehicle. M&A / DealsRead full story Post navigation Previous: Kardigan Blood Pressure Drug Proves Hypothesis Despite Split Phase 2 ReadoutNext: S16 Ep40: FDA Approval Insights: Zongertinib for HER2 TKD-Mutated NSCLC: With Julia Rotow, MD; and Martin Dietrich, MD, PhD Related Stories M&A / Deals Assertio accepts new buyout bid; AI biotech Isomorphic banks $2B pharminent May 13, 2026 M&A / Deals BMS, Hengrui build 13-asset pipeline in $15B+ onco-immune deal pharminent May 12, 2026 M&A / Deals Cellular Intelligence scoops up Novo’s Parkinson’s therapy pharminent May 12, 2026
